Search
Viridian Therapeutics Inc
VRDNAdd to Watchlist
19.890USD
+0.010+0.05%
Close 07-30 16:00（ET）Quotes delayed by 15 min
2.04BMarket Cap
LossP/E TTM
Viridian Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-30The current valuation score of Viridian Therapeutics Inc is 6.85, ranking 276 out of 384 in the Biotechnology & Medical Research industry. Its current P/E ratio is -4.98, which is -56.54% below the recent high of -2.16 and -86.62% above the recent low of -9.29.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.